You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 27, 2025

Drug Price Trends for NDC 51407-0207


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 51407-0207

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
BUPROPION HCL 300MG 24HR TAB,SA Golden State Medical Supply, Inc. 51407-0207-05 500 78.22 0.15644 2023-06-15 - 2028-06-14 FSS
BUPROPION HCL 300MG 24HR TAB,SA Golden State Medical Supply, Inc. 51407-0207-90 90 14.70 0.16333 2023-06-15 - 2028-06-14 FSS
BUPROPION HCL 300MG 24HR TAB,SA Golden State Medical Supply, Inc. 51407-0207-30 30 4.97 0.16567 2023-06-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 3 of 3 entries

Market Analysis and Price Projections for NDC 51407-0207: Bupropion Hydrochloride XL

The pharmaceutical market is constantly evolving, with drug prices and trends playing a crucial role in shaping the industry landscape. In this comprehensive analysis, we'll delve into the market dynamics and price projections for the drug with National Drug Code (NDC) 51407-0207, which is Bupropion Hydrochloride XL, manufactured by Golden State Medical Supply, Inc.

Understanding NDC 51407-0207

Bupropion Hydrochloride XL is an extended-release formulation of bupropion, an antidepressant medication commonly used to treat major depressive disorder and seasonal affective disorder. It's also prescribed to aid in smoking cessation[5].

Current Market Status

As of 2025, the pharmaceutical industry is experiencing significant transformations. The US healthcare market is projected to reach $485 billion in medical spending this year, with an average annual growth rate of 4% to 7%[3]. Within this context, let's examine the specific market conditions for Bupropion Hydrochloride XL.

Price Trends and Projections

While we don't have specific pricing data for NDC 51407-0207, we can infer trends based on similar drugs and market conditions. The pharmaceutical industry is facing pressure to control drug prices, which may impact the pricing of Bupropion Hydrochloride XL.

Health spend is projected to increase an average of 4% to 7% a year, with a 13.3% increase in specialty drug trend according to the annual Segal survey[3].

This trend suggests that while overall drug prices are increasing, there's also a push for more affordable options, especially for commonly prescribed medications like antidepressants.

Factors Influencing Price

Several factors are likely to influence the price of Bupropion Hydrochloride XL in the coming years:

  1. Generic Competition: As patents expire, generic versions of brand-name drugs enter the market, typically leading to price reductions.

  2. Policy Changes: The incoming administration in 2025 may implement new health policies that could affect drug pricing[7].

  3. Market Demand: The prevalence of depression and the need for smoking cessation aids could drive demand for this medication.

  4. Manufacturing Costs: Changes in production costs or supply chain disruptions could impact pricing.

  5. Healthcare Reform: Ongoing debates about healthcare reform and drug pricing legislation could influence future prices.

Market Dynamics

The pharmaceutical market is experiencing several key trends that could impact the pricing and availability of drugs like Bupropion Hydrochloride XL:

Biosimilar Expansion

While not directly related to Bupropion Hydrochloride XL, the expansion of biosimilars in the market is creating a shift towards more affordable treatment options across various therapeutic areas[3].

Focus on Value-Based Care

There's an increasing emphasis on value-based care, which could lead to more scrutiny of drug prices in relation to their effectiveness[7].

Technological Advancements

Innovations in drug development and manufacturing processes could potentially lower production costs, which might be reflected in drug prices.

Comparative Analysis

To better understand the potential pricing for Bupropion Hydrochloride XL, let's look at some comparative data:

  1. Primidone 250mg: Another drug manufactured by Golden State Medical Supply, Inc. (NDC 51407-0638) was priced at $0.25950 per unit as of January 2024[1].

  2. Vitamin D 50000 UNT: This drug (NDC 51407-0143) from the same manufacturer was priced at $0.09950 per unit[2].

While these are different medications, they provide some context for the pricing strategies of Golden State Medical Supply, Inc.

Market Projections

Based on the available data and industry trends, we can make some projections for the Bupropion Hydrochloride XL market:

  1. Stable Pricing: Given the maturity of the bupropion market and the presence of generic options, prices are likely to remain relatively stable.

  2. Potential for Slight Decreases: Increased competition and policy pressures may lead to modest price reductions over time.

  3. Volume Growth: The prevalence of depression and the ongoing need for smoking cessation aids may drive volume growth, even if per-unit prices decrease.

Impact of Healthcare Trends

Several broader healthcare trends are likely to influence the market for Bupropion Hydrochloride XL:

Personalized Medicine

The shift towards personalized medicine could lead to more targeted use of antidepressants, potentially affecting the overall market size for drugs like Bupropion Hydrochloride XL[10].

Digital Health Integration

The integration of digital health technologies could improve medication adherence and patient outcomes, potentially increasing the value proposition of drugs like Bupropion Hydrochloride XL.

Mental Health Awareness

Increasing awareness and destigmatization of mental health issues could lead to higher diagnosis rates and treatment seeking, potentially expanding the market for antidepressants.

Regulatory Considerations

The regulatory environment plays a crucial role in drug pricing and availability. The FDA's National Drug Code Directory, which includes NDC 51407-0207, provides important information about drug products that can influence market dynamics[9].

Future Outlook

Looking ahead to 2025 and beyond, several factors are likely to shape the market for Bupropion Hydrochloride XL:

  1. Policy Changes: The new administration's healthcare policies could significantly impact drug pricing and access.

  2. Technological Advancements: Innovations in drug delivery systems or formulations could create new opportunities or challenges for existing medications.

  3. Shifting Treatment Paradigms: Evolving approaches to treating depression and aiding smoking cessation could influence the demand for Bupropion Hydrochloride XL.

  4. Global Economic Factors: Economic conditions can affect healthcare spending and drug pricing strategies.

Key Takeaways

  • The pharmaceutical market is projected to reach $485 billion in 2025, with an average growth rate of 4-7% annually.
  • Bupropion Hydrochloride XL (NDC 51407-0207) is likely to face pricing pressures due to industry trends towards more affordable treatment options.
  • Factors such as generic competition, policy changes, and healthcare reform will play significant roles in shaping the market for this medication.
  • While specific pricing data for NDC 51407-0207 is not available, comparative analysis with other drugs from the same manufacturer suggests a trend towards competitive pricing.
  • The future market for Bupropion Hydrochloride XL will be influenced by broader healthcare trends, including personalized medicine and digital health integration.
  • Regulatory considerations and potential policy changes in 2025 could have substantial impacts on drug pricing and market dynamics.

FAQs

  1. Q: What is the current price of Bupropion Hydrochloride XL (NDC 51407-0207)? A: While specific pricing data for NDC 51407-0207 is not provided in the available information, industry trends suggest that prices for established generic medications like Bupropion Hydrochloride XL are likely to remain relatively stable or potentially decrease slightly due to market pressures.

  2. Q: How might the 2025 administration change affect the pricing of Bupropion Hydrochloride XL? A: The incoming administration in 2025 may implement new health policies that could affect drug pricing. These changes could potentially lead to increased scrutiny of drug prices and efforts to make medications more affordable.

  3. Q: Are there any expected innovations that could impact the market for Bupropion Hydrochloride XL? A: While not specific to Bupropion Hydrochloride XL, the pharmaceutical industry is seeing advancements in personalized medicine and digital health integration. These innovations could potentially influence how antidepressants are prescribed and used, which may impact the market for this medication.

  4. Q: How does the pricing of Bupropion Hydrochloride XL compare to other drugs from Golden State Medical Supply, Inc.? A: While we don't have specific pricing for Bupropion Hydrochloride XL, other drugs from the same manufacturer, such as Primidone 250mg and Vitamin D 50000 UNT, are priced at $0.25950 and $0.09950 per unit respectively. This suggests that Golden State Medical Supply, Inc. aims for competitive pricing in the generic drug market.

  5. Q: What factors are likely to influence the demand for Bupropion Hydrochloride XL in the coming years? A: Factors that could influence demand include the prevalence of depression and the need for smoking cessation aids, changes in treatment guidelines, increased mental health awareness, and potential shifts in healthcare policies that affect access to mental health treatments.

Sources cited:

  1. https://www.drugpatentwatch.com/p/drug-price/ndc/51407-0638
  2. https://www.drugpatentwatch.com/p/drug-price/ndc/51407-0143
  3. https://www.pharmacytimes.com/view/managing-sustainable-drug-spend-5-trends-reshaping-pharmacy-benefits-in-2025
  4. https://www.findacode.com/ndc/labelers/Golden_State_Medical_Supply,_Inc.--51407
  5. https://www.pwc.com/us/en/industries/pharma-life-sciences/pharmaceutical-industry-trends.html
  6. https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
  7. https://www.labiotech.eu/in-depth/biotech-trends-2025/

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.